Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phas...

Full description

Bibliographic Details
Main Authors:	Holyoake, D, Partridge, M, Hurt, C, Mukherjee, S, Hawkins, M
Format:	Conference item
Published:	Elsevier 2017

Similar Items

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
by: Holyoake, DLP, et al.
Published: (2018)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
by: Holyoake, D, et al.
Published: (2016)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
by: Holyoake, D, et al.
Published: (2017)

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
by: Holyoake, D, et al.
Published: (2019)

Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
by: Holyoake, D, et al.
Published: (2018)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
by: Warren, S, et al.
Published: (2016)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
by: Wilson, J, et al.
Published: (2017)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
by: Witztum, A, et al.
Published: (2016)

Pixel-based analysis of stomach dose-surface maps to improve toxicity predictions in gastrointestinal radiotherapy
by: Witztum, A, et al.
Published: (2017)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
by: Warren, S, et al.
Published: (2014)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
by: Warren, S, et al.
Published: (2017)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
by: Holyoake, D, et al.
Published: (2016)

Investigating the toxicity and safety of radiotherapy for pancreatic cancer
by: Holyoake, D
Published: (2018)

Modelling normal tissue toxicity in pancreatic chemoradiotherapy
by: Witztum, A
Published: (2018)

SU-F-T-108: Texture analysis for toxicity prediction from dose surface maps.
by: Witztum, A, et al.
Published: (2016)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
by: Mukherjee, S, et al.
Published: (2024)

Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT
by: Holyoake, D, et al.
Published: (2016)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
by: Carrington, R, et al.
Published: (2015)

Acute chemoradiotherapy toxicity in cervical cancer patients
by: Radojevic Marija Zivkovic, et al.
Published: (2020-09-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
by: Warren, S, et al.
Published: (2015)

Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy
by: Sara Broggi, et al.
Published: (2023-01-01)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
by: Wilson, J, et al.
Published: (2017)

The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
by: Min Chen, et al.
Published: (2023-04-01)

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy
by: Chang Min Cho
Published: (2018-05-01)

A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
by: Gulliford, S, et al.
Published: (2010)

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
by: Kuniaki Katsui, et al.
Published: (2019-11-01)

ACUTE AND LATE TOXICITY WITH CHEMORADIOTHERAPY FOR OROPHARYNGEAL CANCER DEPENDING ON THE FRACTIONATION OPTION
by: Parkhomenko L. B.
Published: (2018-12-01)

Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy.
by: Jan-Niklas Becker, et al.
Published: (2023-01-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Improper lung volume-dose parameters are risk factors for acute fatal radiation pneumonitis among esophageal cancer patients receiving chemoradiotherapy: a case-control study
by: Ruinuo Jia, et al.
Published: (2025-01-01)

SU-D-BRA-06: Duodenal interfraction motion with abdominal compression.
by: Witztum, A, et al.
Published: (2016)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
by: Kuniaki Katsui, et al.
Published: (2020-07-01)

Primary diffuse large b-cell lymphoma of the stomach presenting as acute pancreatitis
by: Sara Ghani, et al.
Published: (2020-06-01)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
by: Sebastian Zschaeck, et al.
Published: (2017-01-01)

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan
by: Yoshiko Oshiro, et al.
Published: (2021-07-01)

EP-1720: Impact of contouring variability on tumour control and normal tissue toxicity in liver SBRT
by: Robinson, M, et al.
Published: (2016)

The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer
by: Bao-Zhong Zhang, et al.
Published: (2023-01-01)

ECTOPIC PANCREATIC TISSUE IN THE STOMACH: CASE REPORT
by: Dejan Lukic, et al.
Published: (2017-04-01)

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.
by: Guichao Li, et al.
Published: (2013-01-01)

Evaluating the Predictive Value of the Dose-volume Parameters and Vascular Endothelial Growth Factor Expression on Rectal Toxicity in Prostate Cancer Patients
by: Marziyeh Mirzaeiyan, et al.
Published: (2024-12-01)